The FDA will temporarily allow a replacement drug for Doxil, a drug for ovarian and other cancers, to be imported. The drug has not been available to new patients for months. The FDA also approved a supplier for a preservative-free version of methotrexate, which is used to treat children with acute lymphoblastic leukemia and bone cancer.
Related Articles on Supply Chain:
Cardinal Health to Start Offering its Complete Portfolio of Surgical Gloves in Sustainable, Half-Fold Packaging
Teleflex Signs Agreement With HealthTrust for Arrow Intra-Aortic Balloon Pumps and Catheters
SourceMedical Launches Vision OnDemand Clinical and Business Management System for ASCs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
